| Filed On | Filing |
|---|---|
| 13 Nov 2026 | Form 4 |
| 12 Nov 2026 |
Form 4: Juvenal Tobin W, Chief Commercial Officer
Sold 3,288 shares ($107K) · Sold 2,828 shares ($99.1K) |
| 12 Nov 2026 | 144 |
| 09 Nov 2026 | 144 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Delivered Q3 2026 revenue of $102.9 million, an increase of 24% over Q3 2025 |
| 04 Nov 2026 |
Form 4: Maetzold Derek J, Director
Sold 14,496 shares ($523K) |
| 02 Nov 2026 | 144 |
| 30 Oct 2026 |
Form 4: Juvenal Tobin W, Chief Commercial Officer
Sold 6,578 shares ($240K) |
| 29 Oct 2026 | SCHEDULE 13G/A |
| 28 Oct 2026 |
Form 4: Juvenal Tobin W, Chief Commercial Officer
Sold 3,288 shares ($109K) |
| 21 Oct 2026 |
Form 4: Maetzold Derek J, Director
Sold 14,496 shares ($463K) |
| 14 Oct 2026 |
Form 4: Juvenal Tobin W, Chief Commercial Officer
Sold 3,288 shares ($111K) |
| 13 Oct 2026 | 144 |
| 07 Oct 2026 |
Form 4: Maetzold Derek J, Director
Received 8,165 shares by exercise or conversion ($19.5K) · Sold 14,496 shares ($516K) |
| 05 Oct 2026 | 144 |
| 05 Oct 2026 |
Form 4: Oelschlager Kristen M, Chief Operating Officer
Received 4,153 shares by exercise or conversion ($14K) · Sold 4,153 shares ($149K) |
| 01 Oct 2026 | 144 |
| 01 Oct 2026 |
Form 4: Juvenal Tobin W, Chief Commercial Officer
Sold 5,543 shares ($197K) · Sold 1,034 shares ($35.4K) |
| 23 Sep 2026 |
Form 4: Maetzold Derek J, Director
Received 8,580 shares by exercise or conversion ($20.5K) · Sold 14,496 shares ($512K) |
Loading...